DUX4 and facioscapulohumeral muscular dystrophy: In the FSHD research field, several efforts are devoted to clarifying the pathogenetic mechanisms caused by the inappropriate expression of DUX4 in patients’ muscles by evaluating the effects of DUX4 molecular signature on myogenic cells [34–36].